companydata.dkcompanydata.dk

Proxi Biotech ApS: Financial statements 2024

CVR: 39859211

Source: annual report 2024, Danish Business Authority

01/01/2024 – 31/12/2024

Proxi Biotech ApS (CVR 39859211) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK 983,921 and a net result of DKK 426,762 compared with DKK 68,661 the year before. That is an increase of 88.9% compared with the year before. Equity in the 2024 report amounted to DKK 416,867. The solvency ratio was 68%. The company had 1 employee in the financial year.

Gross Profit
DKK 983,921
Profit/Loss
DKK 426,762
Equity
DKK 416,867
Total Assets
DKK 613,109
Employees
1

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2024-984 t.427 t.417 t.1
2023-521 t.69 t.-10 t.1
2022-411 t.-72 t.-79 t.1
2021-461 t.2 t.-6 t.1
2020-337 t.85 t.-9 t.1

Official annual report

View the official annual report directly on the page with a Pro subscription.

Screen every Danish company

Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.

Try company screening

Events in 2024

Proxi Biotech ApS: The 2023 annual report is outMay 23, 2024

Proxi Biotech ApS has published its annual report for 2023. Gross profit came to DKK 520,824, and the net result was DKK 68,661.

About Proxi Biotech ApS

Proxi Biotech ApS is a Danish company of the type Anpartsselskab based in København V, founded in 2018. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named PrOxi Biotech ApS and PrOxi Biotech IVS. The management consists of Rene Jørgensen and Aria Aminzadeh. The board consists of Sten Verland (chair), Aria Aminzadeh, Paul Jefferson Hargreaves and Per Bo Pedersen Fischer. The company is owned by Aminzadeh Holding ApS, Dr RJ Holding ApS and Century House Holding ApS. The company has 6 employees (2026). In 2025, the company reported a gross profit of DKK -430,820 and a net result of DKK -1,688,504 compared with DKK 426,762 the year before. Equity in the 2025 report amounted to DKK -1,712,625.

Source: annual report 2025, Danish Business Authority

Other financial years